Advertising Age - Ad groups unfazed by DTC-drug debacles; Industry still opposes moratorium despite flap over Vytorin, Zyprexa.(News)(Eli Lilly and Co. into investigation for…
Byline: RICH THOMASELLI and IRA TEINOWITZ
First came headlines that a study showing that cholesterol drug Vytorin doesn’t reduce plaque buildup in arteries was delayed by drug makers that spent millions advertising the claim. Then came news that Eli Lilly & Co. might pay an astounding $1 billion to settle a federal investigation into the marketing of its antipsychotic drug Zyprexa, potentially the largest sum ever paid by a drug company for breaking federal laws regarding marketing of prescription medication.
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?
Job Hunt Backlash…How The Tough Questions Can Strangle You!
But the ad industry is standing by its opposition to a two-year …
Read the rest of this article with a Free Trial at HighBeam Research.
